PMA device
R3 Delta Ceramic Hip System
Smith & Nephew, Inc. · Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented (MRA, Class III) · First FDA decision Dec 21, 2016, newest Feb 28, 2025Hip osteoarthritis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
4
Naming "R3 Delta"
MAUDE reports
3
Brand "R3 Delta", since 2015
PubMed studies
1
Mentioning "R3 Delta"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing R3 Delta Ceramic Hip System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
- R3 Delta Ceramic Hip SystemPMA supplement
P150030-S045 · Decided Feb 28, 2025 · 178 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA) · Orthopedic Surgery
5 more FDA decisions with a free account
Older decisions: P150030-S003, P150030-S001
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Heavy Metal TestingLocal determinationIn effectL35074Wellpoint FederalUpdated Jul 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "R3 Delta", any status and sponsor, newest update first.
- OXINIUM◊ DH Total Hip Arthroplasty Pivotal StudyPivotal-lookingActive, not recruiting
Smith & Nephew, Inc.Public (SNN)
NCT02353377 · 413 participants · Start Jan 2015 · Primary completion Sep 21, 2021
Device: OXINIUM DH Hip System; BIOLOX◊ · For: Hip Osteoarthritis
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "R3 Delta", and for the whole product code for context.
This brand
3 reports: 0 malfunction, 3 injury, 0 death
Whole product code MRA
3,565 reports: 1,861 malfunction, 1,695 injury, 9 death
Newest reports for this brand
- R3 DELTA CERAMIC INSERTInjury
1020279-2025-00944 · Received May 25, 2025
Device type: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented (MRA)
Device problem as coded: Material Erosion; Fracture; Device Dislodged or Dislocated; Adverse Event Without Identified Device or Use Problem; Osseointegration Problem; Loosening of Implant Not Related to Bone-Ingrowth
Patient problem as coded: Unspecified Infection; Pain; Local Reaction; Deformity/ Disfigurement; Joint Dislocation; Osteolysis; Inadequate Osseointegration; Unequal Limb Length; Insufficient Information; Aseptic loosening; Periprosthetic fracture
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "R3 Delta"[tiab]. The summary above synthesizes these.
- Mid-term outcomes of the R3ࡊ delta ceramic acetabular system in total hip arthroplasty.
Davis ET, Remes V, Virolainen P, et al. · J Orthop Surg Res · 2021
Other devices of this type
Also filed under product code MRA.
- Ceramax® Ceramic Total Hip SystemDePuy Orthopaedics, Inc. · PMA 2025
- Duraloc Option Ceramic Hip SystemDePuy Orthopaedics, Inc. · PMA 2012
- DePuy Ceramax Ceramic Total Hip SystemDePuy Orthopaedics, Inc. · PMA 2025
- Reflection Ceramic Acetabular Hip System (Rchs)Smith & Nephew, Inc. · PMA 2018
- Novation Ceramic Articulation Hip SystemExactech, Inc. · PMA 2017
- Trilogy Ab Acetabular SystemZimmer, Inc. · PMA 2011
- Ceramic Transcend® Hip Articulation SystemMicroport Orthopedics, Inc. · PMA 2018
- Ceramic Transcend Hip Articulation SystemCeramtec GmbH · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.